Works in Blood Cancer Journal, 2020, Vol 10, Issue 1
Results: 13
Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41408-020-00357-4
- By:
- Publication type:
- Article
Venetoclax plus hypomethylating agents or low-dose cytarabine in acute myeloid leukemia: all that glitters is gold?
- Published in:
- 2020
- By:
- Publication type:
- Letter to the Editor
Correction: Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myeloma.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
SYK is activated by mutated MYD88 and drives pro-survival signaling in MYD88 driven B-cell lymphomas.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41408-020-0277-6
- By:
- Publication type:
- Article
Application of an ex-vivo drug sensitivity platform towards achieving complete remission in a refractory T-cell lymphoma.
- Published in:
- 2020
- By:
- Publication type:
- Letter to the Editor
The significance of genetic mutations and their prognostic impact on patients with incidental finding of isolated del(20q) in bone marrow without morphologic evidence of a myeloid neoplasm.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41408-020-0275-8
- By:
- Publication type:
- Article
Anti-CD30 chimeric antigen receptor T cell therapy for relapsed/refractory CD30+ lymphoma patients.
- Published in:
- 2020
- By:
- Publication type:
- Letter to the Editor
RNA-Seq profiling of deregulated miRs in CLL and their impact on clinical outcome.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41408-019-0272-y
- By:
- Publication type:
- Article
High level MYC amplification in B-cell lymphomas: is it a marker of aggressive disease?
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41408-019-0271-z
- By:
- Publication type:
- Article
A new regulatory mechanism of protein phosphatase 2A activity via SET in acute myeloid leukemia.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41408-019-0270-0
- By:
- Publication type:
- Article
Nucleophosmin mutations confer an independent favorable prognostic impact in 869 pediatric patients with acute myeloid leukemia.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41408-019-0268-7
- By:
- Publication type:
- Article
Comparison of three different serum-free light-chain assays—implications on diagnostic and therapeutic monitoring of multiple myeloma.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41408-019-0267-8
- By:
- Publication type:
- Article
Long-term outcomes of IMiD-based trials in patients with immunoglobulin light-chain amyloidosis: a pooled analysis.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41408-019-0266-9
- By:
- Publication type:
- Article